Therapeutic Group

Indication Dosage

Atezolizumab is a medication used to treat certain types of cancer. It helps your immune system fight cancer cells, and it's often prescribed when other treatments haven't worked. Your doctor may recommend Atezolizumab for your specific type of cancer to help improve your chances of recovery.

As Monotherapy; For The Treatment Of Patients With Locally Advanced Or Metastatic Urothelial Carcinoma (UC), For The Treatment Of Adult Patients With Locally Advanced Or Metastatic Non-small Cell Lung Cancer (NSCLC) After Prior Chemotherapy: 

By IV Infusion: 

• Adults: The Recommended Dose Is 1,200 Mg Administered Intravenously Every Three Weeks. Consult Product Literature 

In Combination With Bevacizumab, Paclitaxel, And Carboplatin, For The First-line Treatment Of Adult Patients With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC). In Patients With Egfr Mutant Or Alk-positive Nsclc, Only After Failure Of Appropriate Targeted Therapies: 

By IV Infusion: 

• Adults: Consult Product Literature And Refer To The Full Prescribing Information For The Combination Therapy

Content

Pregnancy

Positive Evidence Of Risk: Avoid

Stability

Contra Indications

Precautions

Lactation

Side Effects